Filing Details

Accession Number:
0001491877-10-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-24 13:00:00
Reporting Period:
2010-05-20
Filing Date:
2010-05-24
Accepted Time:
2010-05-24 20:11:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
72444 Nabi Biopharmaceuticals NABI Biological Products, (No Disgnostic Substances) (2836) 591212264
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021014 F Geoffrey Cox C/O Gtc Biotherapeutics, Inc.
175 Crossing Blvd.
Framingham MA 01702
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-20 1,908 $5.24 25,679 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2010-05-20 40,000 $0.00 40,000 $5.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 2017-05-20 No 4 A Direct
Footnotes
  1. The purchase reported in this form was made upon election of director to receive a portion of his annual director fee retainer in common stock pursuant to Section 14 of the 2007 Omnibus Equity and Incentive Plan.
  2. The Stock Option (right to buy) is exercisable in four equal installments on August 20, 2010, November 20, 2010, February 20, 2011, and May 20, 2011.